Sanofi Adr Stock Performance
| SNY Stock | USD 58.78 0.33 0.56% |
On a scale of 0 to 100, Sanofi ADR holds a performance score of 23. The entity has a beta of -0.15, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sanofi ADR are expected to decrease at a much lower rate. During the bear market, Sanofi ADR is likely to outperform the market. Please check Sanofi ADR's potential upside, as well as the relationship between the daily balance of power and relative strength index , to make a quick decision on whether Sanofi ADR's existing price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sanofi ADR are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Sanofi ADR showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.32 | Five Day Return 3.03 | Year To Date Return 22.66 | Ten Year Return 17.75 | All Time Return 98.56 |
Forward Dividend Yield 0.0346 | Payout Ratio | Last Split Factor 5:1 | Forward Dividend Rate 2.04 | Dividend Date 2024-06-06 |
1 | Odronextamab BLA Accepted for FDA Review for the Treatment of RelapsedRefractory Follicular Lymphoma | 02/26/2025 |
2 | Full-Year 2024 Results - Progress on the implementation of the FOCUS-27 plan driven by enhanced effectiveness and financial discipline | 03/03/2025 |
3 | Why Is Regeneron Down 4.1 percent Since Last Earnings Report | 03/06/2025 |
4 | DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results | 03/10/2025 |
5 | Top 3 Health Care Stocks That May Keep You Up At Night In Q1 | 03/11/2025 |
6 | Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light Can The Bullish Run Continue | 03/12/2025 |
7 | Communiqu de presse - Top dpart pour Place dAvenir 2025 Sanofi recrute 1000 alternants avec Mozak RH | 03/13/2025 |
8 | Jim Cramer On Regeneron Pharmaceuticals Inc. I Want You to Own It | 03/14/2025 |
| Begin Period Cash Flow | 8.7 B |
Sanofi |
Sanofi ADR Relative Risk vs. Return Landscape
If you would invest 4,750 in Sanofi ADR on December 19, 2024 and sell it today you would earn a total of 1,161 from holding Sanofi ADR or generate 24.44% return on investment over 90 days. Sanofi ADR is generating 0.3795% of daily returns assuming volatility of 1.2962% on return distribution over 90 days investment horizon. In other words, 11% of stocks are less volatile than Sanofi, and above 93% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Sanofi ADR Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sanofi ADR's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sanofi ADR, and traders can use it to determine the average amount a Sanofi ADR's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2928
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SNY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.3 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.29 actual daily | 23 77% of assets perform better |
Based on monthly moving average Sanofi ADR is performing at about 23% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sanofi ADR by adding it to a well-diversified portfolio.
Sanofi ADR Fundamentals Growth
Sanofi Stock prices reflect investors' perceptions of the future prospects and financial health of Sanofi ADR, and Sanofi ADR fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sanofi Stock performance.
| Return On Equity | 0.073 | ||||
| Return On Asset | 0.0428 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 156.23 B | ||||
| Shares Outstanding | 2.51 B | ||||
| Price To Earning | 7.78 X | ||||
| Price To Book | 1.75 X | ||||
| Price To Sales | 3.34 X | ||||
| Revenue | 44.29 B | ||||
| Gross Profit | 31.09 B | ||||
| EBITDA | 11.03 B | ||||
| Net Income | 5.5 B | ||||
| Cash And Equivalents | 6.9 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 17.91 B | ||||
| Debt To Equity | 0.30 % | ||||
| Current Ratio | 1.30 X | ||||
| Book Value Per Share | 61.83 X | ||||
| Cash Flow From Operations | 9.08 B | ||||
| Earnings Per Share | 2.40 X | ||||
| Market Capitalization | 147.72 B | ||||
| Total Asset | 132.8 B | ||||
| Retained Earnings | 67.5 B | ||||
| Working Capital | 13.43 B | ||||
| Current Asset | 24.93 B | ||||
| Current Liabilities | 16.82 B | ||||
About Sanofi ADR Performance
Evaluating Sanofi ADR's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Sanofi ADR has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sanofi ADR has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 260.68 | 176.18 | |
| Return On Tangible Assets | 0.08 | 0.14 | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Assets | 0.04 | 0.08 | |
| Return On Equity | 0.07 | 0.13 |
Things to note about Sanofi ADR performance evaluation
Checking the ongoing alerts about Sanofi ADR for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sanofi ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Latest headline from finance.yahoo.com: Jim Cramer On Regeneron Pharmaceuticals Inc. I Want You to Own It |
- Analyzing Sanofi ADR's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sanofi ADR's stock is overvalued or undervalued compared to its peers.
- Examining Sanofi ADR's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sanofi ADR's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sanofi ADR's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sanofi ADR's stock. These opinions can provide insight into Sanofi ADR's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.